Ahmad S Alotaibi Musa Yilmaz Sanam Loghavi Courtney DiNardo Gautam Borthakur Tapan M Kadia Beenu Thakral Naveen Pemmaraju Ghayas C Issa Marina Konopleva Nicholas J Short Keyur Patel Guilin Tang Farhad Ravandi Naval Daver
10.3389/fonc.2020.588876
Front Oncol
2020 Oct 20;10:588876.
aml bcr-abl flt3 flt3 inhibitors secondary mutations
CC BY
https://pubmed.ncbi.nlm.nih.gov/33194747/
Case Reports
PMC7606916
33194747
Emergence of BCR- ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series
2020